Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Liabilities from Discontinued Operations (2016)

Niagen Bioscience (NAGE) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 184766.0 as the latest value for Q4 2016.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 184766.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was 184766.0 through Dec 2016, changed N/A year-over-year, with the annual reading at 184766.0 for FY2016, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q4 2016 was 184766.0 at Niagen Bioscience.
  • The five-year high for Liabilities from Discontinued Operations was 184766.0 in Q4 2016, with the low at 184766.0 in Q4 2016.